Gilead Sciences 2017 J.P. Morgan Healthcare Conference

Gilead Sciences presented at the 35th Annual J.P. Morgan Healthcare Conference in January 2017, detailing 2016 successes including launches of four new products (Descovy, Odefsey, Epclusa, and Vemlidy) and pipeline progress across HIV, HCV, HBV, and inflammatory disease programs. The presentation covers financial projections, risk factors, and clinical development timelines for investigational compounds.